Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNEL.L Regulatory News (CNEL)

  • There is currently no data for CNEL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

30 Sep 2014 08:35

RNS Number : 9736S
China New Energy Ltd
30 September 2014
 



30 September 2014

 

China New Energy Limited

("China New Energy" "CNE" or "the Group")

 

 

Half-yearly report for the six months to 30 June 2014

 

China New Energy Limited (AIM: CNEL), the engineering and technology solutions provider to the bioenergy sector, announces its unaudited half-yearly results for the six months ended 30 June 2014.

 

Financial Highlights

 

· Total contractedamount for the period increased by 159.5% to RMB 49.57m (H1 2013: RMB 19.1m)

· Revenue for the period of RMB 16.4m (H1 2013: RMB 20.1m)

· Gross profit of RMB 2.98m (H1 2013: RMB 2.67m)

· Improved gross margin of 18.2% (H1 2013: 13.2%)

· Decreased loss for the financial period of RMB 4.55m (H1 2013: loss of RMB 5.39m)

· Loss per share of RMB 0.01425 (H1 2013: RMB 0.0097)

 

Operational Highlights

 

· Subscription of £594,766 by Hong Kong listed group China Best Group Holding Limited, for working capital to assist with current projects

· CNE entered into a second agreement with Ubon Bio Ethanol Co., Ltd for the building of a second biorefinery in Thailand, which is expected to commence in late 2014 or early 2015

· Sunbird Bioenergy Africa Limited is progressing planning negotiations Nigeria, with this project expected to start in 2015

· Contracts with a Hungarian company to build two biorefineries progressed to preparation of detailed executive plan and expected to be executed in 2015

· CNE terminated the proposed acquisition of BAPP Ethanol Holdings Limitedafter findings from due diligence

· ZKTY won the China Alcoholic Drinks Association's annual award for Science and Technology Improvement

· Current balance of order book stands at RMB 665m.

 

 

 

Yu Weijun, Chairman, commented:

 

"Our focus during the first half of the year was to develop our pipeline of international projects. In this respect, I am pleased to report that during the first half of 2014 our total contracted amount increased by 159.5%, when compared with the same period in 2013. We expect for work on our second bioethanol project in Thailand to commence this year or in early 2016. We continue to make progress in Europe and Africa and expect that planning consent for our projects in Hungary and Nigeria will be granted and that these projects will commence in 2015.

 

Looking further ahead, we remain confident that low-carbon biofuel will be a clear alternative to fossil fuel and that growth will return to the bioenergy sector. We continue to look to the long-term future with confidence."

 

 

Enquiries:

 

China New Energy Limited

www.chinanewenergy.co.uk

Richard Bennett

Tel: +44 (0)20 7148 3148 or rbennett@zkty.com.cn

Ivy Xu

Tel: +86 (0)20 8705 9371 or xuhj@zkty.com.cn

Cairn Financial Advisers LLP (NOMAD)

Tel: +44 20 7148 7900

Jo Turner / Liam Murray

Daniel Stewart & Company Plc (Broker)

Tel: +44 20 7776 6550

Martin Lampshire

Chairman's Statement

 

On behalf of the Board, I am pleased to present CNE's unaudited half-yearly results for the six month period ended 30 June 2014.

 

Financial Review

 

Revenue for the first six months of the year decreased to RMB 16.4m (H1 2013: RMB 20.1m), while the Group's gross profit increased to RMB 2.98m (H1 2013: RMB 2.67m). The Group's loss for the financial period was also reduced to RMB 4.5m (H1 2013: RMB 5.4m). Due the cyclical nature of our business, historically we usually make a loss in the first half of the year as most projects are completed and paid for in the second half of the year.

 

Selling and distribution expenses decreased by 26.98% to RMB 1.38m (H1 2013: RMB 1.89m), while administrative expenses increased by 1.4% to RMB 5.22m (H1 2013: RMB 5.15m), as no incentives were granted to employees through the company's Employee Benefit Trust. The Group's other operating expenses increased to RMB 0.76m (H1 2013: RMB 0.72m). Finance expenses decreased by 49% to RMB 0.22m (H1 2013: RMB 0.43m), due to reduced debt.

 

 

Operational Review

In the first half of 2014, the Group secured several small contracts for its products and services in China's domestic market. The Group's total contracted amount rose by 159.5% to RMB 49.57m (H1 2013: RMB 19.1 million).

 

The successful completion of the Ubon Bio Ethanol Co., Ltd ("UBBE") project is a testament to the Group's ability to design and construct high quality cassava or molasses based ethanol production facilities. Based upon this successful project, UBBE has entered into a memorandum of understanding to commission a second project and additional auxiliary facilities within a two-year period. We are expecting for this project to commence in the second half of 2015 or the first half of 2016. The successful completion of this project has given CNE a key reference site, which has helped the Group to win new business opportunities in South East Asia and Africa, where there is abundance of inexpensive cassava feedstock. 

 

In South East Asia, CNE secured two contracts in Burma during 2013, which were completed in H1 2014. The total contract value of these Burmese projects was RMB 18 million.

 

In Africa, our development partner, Sunbird Bioenergy, signed a letter of intent in 2013 with Nigeria's Federal Ministry of Agriculture and Rural Development to expand agricultural investment and operations in Nigeria, via the construction of 10 biorefineries in the country. Sunbird Bioenergy continues to make progress, despite being slowed by the Ebola outbreak, and is negotiating planning consent for their first flagship biorefinery in Edo State. This project is scheduled to commence in 2015.

 

At the end of last year, the Company entered into a memorandum of understanding to acquire BAPP Ethanol Holdings Limited ("BAPP"), a wholly owned subsidiary of Sino Distillery Group Limited. This proposed acquisition was intended to allow CNE to meet its stated strategic goal of expanding its core operation from an engineering, procurement and construction services provider to an operating company. However, findings from the legal and financial due diligence process determined that the completion of this transaction would have led to significant capital commitments for the Group, which would have required the Company to raise significant funds. Accordingly, the board decided to terminate acquisition discussions. We remain focused on our core strategy and delivering our existing project pipeline, but still believe that acquisitions may play a significant role in the Group's overall strategy in the future.

 

On 22 April, 2014, CNE's wholly owned subsidiary, Guangdong Zhongke Tianyuan New Energy Technology Co., Ltd ("ZKTY"), won the China Alcoholic Drinks Association's 2013 annual award for Science and Technology Improvement. This recognition was received in respect of the Group's patented Five-Tower Two-stage Differential Pressure Distillation Equipment & Process for Superfine-grade Edible Alcohol technology (Patent Number ZL 2007 1 0030550.8). This technology was designed for ZKTY's client Jilin Province New Tian Long Wine Co., Ltd and was installed at their commercial distillery which has an edible alcohol production capacity of 120,000 tonnes per year. This edible alcohol is blended with other products and is sold in the alcoholic drinks market across China.

 

Outlook

 

After the recent volatility in the global financial markets and the downturn in the bioethanol market, there is a risk that the Group may continue to face difficult trading conditions. As a result the Board maintains its cautious approach to business. Nevertheless, the Board remains positive about the Group's prospects and outlook within the biofuel industry.

 

Identifying new lines of business with recurring income remains a priority for management. During the first half of 2014, the Group conducted initial due diligence on a number of potential acquisitions that meet this criteria. The Board continues to seek M&A opportunities which have the potential to deliver recurring income and stable cash flows and will update the market in this respect as and when appropriate.

 

China is an important participant in the global energy markets. In the interests of its energy security, the PRC government has enacted various laws and regulations encouraging the use of renewable energy as a substitute for fossil fuels. Bioenergy is widely considered to be one of the key alternatives to fossil fuel use, because of its easy acquisition and cleaner emissions. Our strategy is to craft core competence in the provision of the full spectrum of engineering and technology solutions for the renewable fuel and chemicals sector. We strive to provide superior technology and engineering solutions for the bioenergy and biochemical sectors, ranging from feedstock conversion through to end waste management, enabling producers in these sectors to achieve environmentally friendlier products and improve operating margins.

 

The global recession, especially in the U.S. and Europe, may further impede the resources available for research and development activities in our industry. The Group, however, intends to continue to channel its own resources into biofuel production research and development, by relying on our qualified staff and by collaborating with external institutions. Our collaboration partners include the Guangzhou Institute of Energy Conversion ("GIEC"), which is part of the Chinese Academy of Sciences. GIEC is a leading research institute in the PRC, which specialises in the research of alternative and renewable energy technologies. We believe our close long-term working relationship with GIEC will help us to commercialise our R&D faster and at a lower cost.

 

The Directors and management team are confident in the Group's outlook and are determined to position the Group for growth. To strengthen our market position and to add value to our existing business, the Group is also actively exploring opportunities to expand into complementary businesses or operations through acquisitions, joint ventures or strategic alliances.

 

While the Board maintains its cautious approach in view of the current global macro-economic conditions and a slowdown in demand for ethanol, the Group also continues to explore opportunities and negotiate new projects with prospective customers in the PRC and internationally.

 

 

Yu Weijun

Chairman

 

29 September 2014Consolidated Statement of Financial Position

Unaudited

Unaudited

Audited

Six months to 30 June

Six months to 30 June

Year to 31 December

2014

2013

2013

Note

RMB'000

RMB'000

RMB'000

Non-current assets

Property, plant and equipment

10,582

9,841

11,747

Intangible assets

6,500

4,935

6,392

Trade receivables

3,523

3,523

3,523

Investments in subsidiaries

150

30,950

150

20,755

49,249

21,812

Current assets

Inventories

22,313

8,564

15,689

Due from customers for construction contracts

45,676

89,769

48,516

Financial asset at fair value through profit and loss

Trade and other receivables

44,495

54,762

42,249

Notes receivables

1,940

800

15,198

Cash and cash equivalents

15,053

10,965

11,310

129,477

164,860

122,661

Current liabilities

Trade and other payables

91,713

92,734

88,702

Due to customers for construction contracts

20,077

12,298

15,414

Notes payables

3,000

500

Income tax payable

8,825

8,796

8,767

Short-term borrowing

6,600

6,600

6,600

Interest payable

Convertible bonds

23,318

130,215

144,246

119,483

Net current (liabilities)/assets

(738)

20,614

3,178

Non-current liabilities

Deferred tax liabilities

815

815

815

815

815

815

Net (liabilities)/assets

19,202

69,048

24,175

Equity and reserves

Share Capital

2

1,214

1,134

1,214

Share premium

49,118

39,171

49,118

Combination reserve

(33,156)

(33,156)

(33,156)

Warrants reserve

1,673

1,673

1,673

Statutory reserve

12,328

12,328

12,328

Convertible bonds reserve

6,549

Own shares

(5,853)

(5,853)

(5,853)

Accumulated earnings/(losses)

(29,239)

22,567

(24,690)

Foreign currency translation reserve

23,118

24,635

23,541

19,202

69,048

24,175

 

 

 

Consolidated Statement of Comprehensive Income

 

Unaudited

Unaudited

Audited

Six months to 30 June 2014

Six months to 30 June 2013

Year to 31 December 2013

Note

RMB'000

RMB'000

RMB'000

Revenue

16,392

20,158

43,817

Cost of sales

(13,408)

(17,494)

(46,155)

 

 

 

Gross profit

2,983

2,664

(2,338)

Other operating income

63

102

1,147

Investment Income

Selling and distribution expenses

(1,382)

(1,891)

(3,626)

Administrative expenses

(5,224)

(5,153)

(11,987)

Other operating expenses

(757)

(721)

(1,695)

Finance expenses

(222)

(432)

(995)

Bad debt(provision)/write back

(33,772)

Impairment loss on investment

(30,800)

Gain on redemption of bond

 

 

24,866

Profit/(loss) before income tax

(4,539)

(5,431)

(59,200)

Income tax expense

(10)

44

7

 

 

 

Profit/(loss) for the financial period

(4,549)

(5,387)

(59,193)

Other comprehensive income:

Exchange difference

(424)

2,290

1,196

(4,973)

(3,097)

(57,997)

Total comprehensive income for the financial year

(4,973)

(3,097)

(57,997)

Total comprehensive income attributable to equity holder

Earnings/(loss) per share (RMB):

Basic

4

(0.01425)

(0.0097)

(0.185)

Diluted

4

(0.01459)

(0.0097)

(0.190)

 

 

Consolidated Statement of Cash flows

 

Unaudited

Unaudited

Audited

Six months to 30 June

Six months to 30 June

Year to 31 December

2014

2013

2013

RMB'000

RMB'000

RMB'000

Operating activities

Profit/(loss) before income tax

(4,549)

(5,431)

(59,200)

Adjustments for:

Depreciation and amortisation

1,274

1,096

2,219

Administrative expenses - issue of shares to employees

 

Bad debt written back

33,772

Loss/(gain) on disposal of property, plant and equipment

(242)

(223)

Loss/(gain) on disposal of financial assets

Redemption of bond

(24,866)

Interest income

(24)

(119)

(153)

Finance expense

266

443

995

Impairment of investment

30,800

Operating cash flows before movements in working capital

(3,033)

(4,253)

(16,656)

Inventories

(6,615)

3,722

(3,412)

Construction work-in-progress

7,503

(1,164)

29,108

Trade and other receivables

(2,225)

(4,333)

(11,495)

Notes receivables

(940)

6,800

6,600

Trade and other payables

3,011

(3,167)

(1,117)

Notes payables

3,000

(2,562)

(5,404)

Deferred tax

 

 

 

Cash generated from/(used in) operations

701

(4,957)

(2,376)

Income taxes paid

(10)

(224)

(246)

Dividend received

 

 

 

Net cash from/(used in) operating activities

691

(5,181)

(2,622)

Investing activities

Proceeds from disposal of property, plant and equipment

Proceeds from trading financial assets

Acquisition of property, plant and equipment

(8)

(2,956)

Acquisition of intangible assets

(209)

(1,831)

Payment for associated company in the course of acquisition

Net cash from/(used in) investing activities

(217)

(4,787)

 

 

 

Financing activities

Short-term borrowing

6,600

6,600

Proceeds from issuance of shares

 -

 -

10,027

Redemption of convertible bonds

 -

 -

-

interest received

 -

 -

-

Proceeds from issuance/ (redemption) of convertible bonds

(1,763)

(4,488)

Redemption of bonds

(7,506)

 -

Interest received

24

119

153

Interest paid

(220)

(120)

(995)

Net cash from/(used in) financing activities

(196)

4,836

(11,297)

 

 

 

Net increase/(decrease) in cash and cash equivalents

278

(345)

3,888

Cash and bank balances at beginning of period

15,198

11,310

11,310

Effect of foreign exchange rate changes in cash and bank balances

(423)

-

Cash and cash equivalents at end of period

15,053

10,965

15,198

 

 

 

Consolidated Statement of Changes in Equity

Share capital

Share premium

Combination

Statutory reserve

Convertible bonds reserve

Warrants reserve

Own shares

Accumulated earnings/ (losses)

Foreign currency translation reserve

Total

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

Balance at 31 December 2012

1,134

39,171

-33,156

12,328

6,549

1,673

-5,853

 

27,954

 

22,345

 

72,145

Profit for the period

-

-

-

-

-

-

-

-59,193

-59,193

Exchange difference arising on the translation

-

-

-

-

-

-

-

 

1,196

1,196

Total comprehensive income for the period

-

-

-

-

-

-

-

-59,193

1,196

-57,997

Issue of shares, net of share issue costs

80

9,947

10,027

Shares granted to Employee Benefit Trust

Redemption of Bond

-6,549

6,549

Balance at 31 December 2013

1,214

49,118

-33,156

12,328

1,673

-5,853

 

(24,690)

 

23,541

 

24,175

Profit for the period

-

-

-

-

-

-

-

-4,549

-4,549

Exchange difference arising on the translation

-

-

-

-

-

-

-

-424

-424

Total comprehensive income for the period

-

-

-

-

-

-

-

-4,549

-424

-4,973

Issue of warrants

-

-

Issue of shares, net of share issue costs

-

-

-

-

Shares granted to Employee Benefit Trust

-

-

Transfer to statutory reserve

-

-

Balance at 30 June2014

1,134

39,171

-33,156

12,328

6,549

1,673

-5,853

 

(29,239)

 

23,117

 

19,202

 

 

Notes to the Interim Financial Information - Period ended 30 June 2014

 

1. Basis of preparation

 

The financial statements have been prepared in accordance with the International Financial Reporting Standards (IFRS) as adopted by the European Union. The principal accounting policies used in preparing the interim results are those the group expects to apply in its financial statements for the year ending 31 December 2014 and are unchanged from those disclosed in the group's Report and Financial Statements for the year ended 31 December 2013, except for the following additional accounting policies:

 

Basis of consolidation

The Group includes the assets and liabilities of the Employee Benefit Trust ("EBT") within its Statement of Financial Position. In the event of the winding up of the Group, neither the shareholders nor the creditors would be entitled to the assets of the EBT.

 

Long-term incentive scheme charge

The fair value of the employee services received in exchange for the grant of shares or share options is recognised as an expense.

 

The total amount to be expensed over the performance period, from grant date to vesting date, is determined by reference to the fair value of the shares determined at the date the employee is deemed to be fully aware of their potential entitlement and all conditions of vesting.

 

Own shares

Company shares held by the EBT are deducted from the shareholders' funds and classified as Own Shares until such time as they vest unconditionally to participating employees and their families.

 

This interim financial information has not been reviewed or audited by the Group's auditors. The comparatives for the period ended 31 December 2013 are not the Group's full statutory accounts for that period but have been extracted from those financial statements. A copy of the statutory financial statements for that period, which were prepared under IFRS, has been delivered to the Companies Registry. The auditors' report on those accounts was unqualified.

 

Whilst the financial information included in this Interim Financial information has been prepared in accordance with the recognition and measurement criteria of IFRS, it does not include sufficient information to comply with IFRS.

 

This interim report was approved by the Board of directors on 29 September 2014.

 

 

2. Ordinary shares

 

 

 Number of Shares

 Share Capital

 Share premium

 £ '000

 RMB '000

 £ '000

 RMB '000

 As at 31st December 2010

6,733,107

67

1,013

1,952

29,354

 As at 21st March 2011

67,331,070

67

1,013

1,952

29,354

 As at 6 May 2011

269,324,280

67

1,013

1,952

29,354

 Shares issued in connection with the Placing

9,360,147

2

24

653

6,756

 Share issued in settlement of fees to professional

9,920,295

2

26

692

7,160

 Share issued to EES Trustees International Limited

8,079,728

2

21

564

5,832

 Shares issued to Citadel pursuant to warrant agreement

7,932,412

2

20

305

3,152

 Placing on 14 Dec 2011

6,000,000

2

14

258

2,650

Less share issue costs

-

-

(16,303)

 As at 31 December 2011

310,616,862

1,118

38,601

Placing on 25 Sept 2012

6,000,000

2

15

59

601

Less share issue costs

(3)

(31)

 As at 31 December 2012

316,616,862

1,133

39,171

As at 30 June 2013

316,616,862

1,133

39,171

Placing on 4 Nov 2013

10,000,000

3

24

248

2,425

Less share issue costs

(17)

(171)

Placing on 25 Nov 2013

8,571,429

2

21

298

2,966

Less share issue costs

(21)

(209)

Placing on 26 Nov 2013

6,666,667

2

17

248

2,462

Placing on 29 Nov 2013

7,107,143

2

18

246

2,474

As at 31 December 2013

348,962,101

1,214

49,118

As at 30 June 2014

348,962,101

1,214

49,118

 Total shares in issue

348,962,101

 

 

 

The substantial shareholders have not changed from 31 December 2013. The Group has one class of ordinary shares which carry no right to fixed income.

 

 

3. Employee Benefit Trust

 

In accordance with the requirements of SIC 12 "Consolidation-special purpose entities" and IAS 32 "Financial Instruments: Presentation", certain of the assets and liabilities of the EBT have been included in the company's and Group's accounts resulting in the inclusion of RMB 21,000 own shares and RMB 5,832,000 share premium. This represents shares held by the Employee Benefit Trust that had not vested to employees.

 

On 24 March 2011,the shareholders approved the establishment of the China New Energy Limited Employee Benefit Trust (the "EBT") and the associated share scheme as part of the company's employee incentive arrangements. The scheme provided for the issue of up to 8,079,728 shares to employees in respect of the one year ended 23 May 2012 for nil consideration.

 

As required by SIC 12-"Consolidation - Special Purpose Entities" and IAS 32 the EBT is included in the company's and Group's accounts, accordingly this shareholding of 8,079,728 ordinary shares is represented in the Statement of Changes In Equity as Own Shares (RMB 5,853,000).

 

 

4. Earnings per share

 

Earnings per share ("EPS") on a basic and diluted basis are as follows:

 

Earnings per share ("EPS") on a basic and diluted basis are as follows:

Earnings

Weighted average number of shares

Earning per shares

Earnings

Weighted average number of shares

Earning per shares

Six months

Six months

Six months

Six months

Six months

Six months

to 30 June

to 30 June

to 30 June

to 30 June

to 30 June

to 30 June

2014

2014

2014

2013

2013

2013

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

RMB'000

Earnings/(loss)per share-basic

(4,973)

348,962,101

(0.01425)

(3,097)

316,616,862

(0.0097)

Potentially dilutive shares

-

-

-

-

-

Earnings/(loss)per share-diluted

(4,973)

348,962,101

(0.01459)

(3,097)

316,616,862

(0.0097)

 

 

5. Directors' interests

 

The following Directors have held office during the period and their interests as at 30 June 2014, all of which are beneficial unless otherwise stated, whether direct or indirect, of the Directors and their families in the issued share capital of the company and options over Ordinary Shares which had been granted, are as follows:

 

Director

Number of Ordinary Shares

Percentage of Ordinary Shares

Yu Weijun

90,932,440

26. 06%

Tang Zhaoxing

48,000,000

13.76%

Richard Bennett

-

-

 

6. Business Segment

 

The CNE Group's assets, liabilities and capital expenditure are almost entirely attributable to a single business segment of provision of technology and engineering services to ethanol, ethanol downstream product and biobutanol producers. Therefore, the CNE Group does not have separately reportable business segments under IFRS 8 Segmental Reporting. Nonetheless the CNE Group's revenue and results can be classified into the following streams:

 

a. EPC of plants producing ethanol and ethanol downstream products ("EPC activities"); and

b. Value-added and other value added services ("VAS") services.

 

Revenue

EPC

VAS

Total

RMB'000

RMB'000

RMB'000

Unaudited six months to 30 Jun 2014

15,605

787

16,392

Unaudited six months to 30 Jun 2013

16,141

4,017

20,158

Year ended 31 Dec 2013

35,671

8,146

43,817

Results

Unaudited six months to 30 Jun 2014

2,943

40

2,983

Unaudited six months to 30 Jun 2013

2,090

574

2,664

Year ended 31 Dec 2013

(3,285)

947

(2,338)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR WGUWWBUPCUMU
Date   Source Headline
14th Jul 20206:00 pmRNSChina New Energy
14th Jul 20204:49 pmRNSHKEx Admission and Cancellation of Trading on AIM
14th Jul 20202:05 pmRNSSecond Price Monitoring Extn
14th Jul 20202:00 pmRNSPrice Monitoring Extension
14th Jul 202011:06 amRNSSecond Price Monitoring Extn
14th Jul 202011:00 amRNSPrice Monitoring Extension
14th Jul 20207:00 amRNSGlobal Offering, Issue of Equity and HKEx update
30th Jun 20207:00 amRNSPublication of Prospectus and Global Offering
29th Jun 20204:40 pmRNSSecond Price Monitoring Extn
29th Jun 20204:35 pmRNSPrice Monitoring Extension
23rd Jun 20207:00 amRNSHong Kong Listing Update
8th Jun 202011:05 amRNSSecond Price Monitoring Extn
8th Jun 202011:00 amRNSPrice Monitoring Extension
30th Apr 20201:08 pmRNSConvertible Loan Extension
16th Apr 202010:31 amRNSResult of AGM
30th Mar 202011:56 amRNSResubmission of Hong Kong Listing Application
26th Mar 20201:53 pmRNSPosting of Circular and Notice of AGM
26th Mar 202012:56 pmRNSFinal Results
11th Feb 20207:00 amRNSTrading Update and Coronavirus Information
4th Feb 20202:05 pmRNSSecond Price Monitoring Extn
4th Feb 20202:00 pmRNSPrice Monitoring Extension
8th Jan 20207:00 amRNSHong Kong Listing Update
24th Oct 20198:36 amRNSDirector/PDMR Shareholding
23rd Oct 201910:35 amRNSResult of EGM
15th Oct 20192:05 pmRNSSecond Price Monitoring Extn
15th Oct 20192:00 pmRNSPrice Monitoring Extension
7th Oct 20197:00 amRNSDirector/PDMR Shareholding
3rd Oct 20194:35 pmRNSPrice Monitoring Extension
2nd Oct 20193:28 pmRNSPosting of Circular and Notice of EGM
27th Sep 20193:45 pmRNSHalf-year Report
5th Sep 20192:05 pmRNSSecond Price Monitoring Extn
5th Sep 20192:00 pmRNSPrice Monitoring Extension
3rd Sep 20194:41 pmRNSSecond Price Monitoring Extn
3rd Sep 20194:36 pmRNSPrice Monitoring Extension
29th Jul 201910:13 amRNSResult of AGM
26th Jul 20192:11 pmRNSDirector/PDMR Shareholding
23rd Jul 20194:11 pmRNSHolding(s) in Company
23rd Jul 20193:31 pmRNSHolding(s) in Company
22nd Jul 201911:20 amRNSDirector/PDMR Shareholding
28th Jun 20198:31 amRNSNotice of AGM
25th Jun 20197:00 amRNSUpdate re Listing
19th Jun 20195:59 pmRNSFinal Results
16th Apr 20197:00 amRNSDirector/PDMR Shareholding
15th Mar 20197:00 amRNSDirector's Dealing
21st Feb 20197:00 amRNSAppointment of Broker
8th Feb 20199:05 amRNSSecond Price Monitoring Extn
8th Feb 20199:00 amRNSPrice Monitoring Extension
4th Feb 20197:00 amRNSConvertible Loan Agreement
17th Dec 20184:39 pmRNSTrading Update
24th Sep 20187:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.